Olon Overview
- Year Founded
-
1985
- Status
-
Private
- Employees
-
2,800
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$26.2M
Olon General Information
Description
Producer of Active Pharmaceutical Ingredients in Rodano, Milan. The company specializes in chemical synthesis, contract manufacturing, biological processing, process improvement, and other related services to its clients.
Contact Information
Website
www.olonspa.comCorporate Office
- Strada Rivoltana Kilometer 6-7
- 20053 Rodano(Milan)
- Italy
Corporate Office
- Strada Rivoltana Kilometer 6-7
- 20053 Rodano(Milan)
- Italy
Olon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Debt - General | 22-Dec-2022 | $26.2M | Completed | Generating Revenue |
Olon Comparisons
Industry
Financing
Details
Olon Competitors (1)
One of Olon’s competitors is IMCoPharma, a Private Equity-Backed company based in Bilovec, Czech Republic.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IMCoPharma | Private Equity-Backed | Bilovec, Czech Republic |
Olon Patents
Olon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026088098-A1 | Adagrasib oxalate of crystalline form a and process for its preparation | Pending | 23-Oct-2024 | ||
| WO-2026033478-A1 | Process for preparing 3-piperidin-4-il-1h- quinolin-2-one or a salt thereof and its use as an intermediate for the preparation of pharmaceutical active ingredients antagonists of the cgrp peptide receptor | Pending | 09-Aug-2024 | ||
| WO-2026003773-A1 | Process for preparing venetoclax, and method for preparing an amorphous form of venetoclax | Pending | 27-Jun-2024 | ||
| WO-2025238595-A1 | Process for preparing (r)-2-amino-3-(7-methyl-1h-indazol-5-yl) methyl propanoate, and use thereof as intermediate for the synthesis of zavegepant | Pending | 16-May-2024 | ||
| WO-2025219882-A1 | Process for preparing pentadecanoic acid | Pending | 16-Apr-2024 | C25B3/07 |
Olon Signals
Olon Investments & Acquisitions (7)
Olon’s most recent deal was a Merger/Acquisition with Huvepharma. The deal was made on 04-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Huvepharma | 04-Sep-2024 | Merger/Acquisition | Pharmaceuticals | ||
| GTP Bioways | 03-Jul-2024 | Merger/Acquisition | BPO/Outsource Services | ||
| Olon (API Manufacturing Plant in Mahad, Maharashtra) | 05-Apr-2019 | Corporate Asset Purchase | Buildings and Property | ||
| Capua Bioservices | 25-Jan-2019 | Merger/Acquisition | Biotechnology | ||
| API production facility | 03-Sep-2018 | Corporate Asset Purchase | Buildings and Property |
Olon Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Capua Bioservices | Capua, Italy | 2014 | |
| GTP Bioways | Toulouse, France | 2000 | |
| Huvepharma | Peachtree City, GA | 1954 | |
| INFA GROUP | Milan, Italy | 1953 |
Olon FAQs
-
When was Olon founded?
Olon was founded in 1985.
-
Where is Olon headquartered?
Olon is headquartered in Rodano, Italy.
-
What is the size of Olon?
Olon has 2,800 total employees.
-
What industry is Olon in?
Olon’s primary industry is Pharmaceuticals.
-
Is Olon a private or public company?
Olon is a Private company.
-
What is Olon’s current revenue?
The current revenue for Olon is .
-
How much funding has Olon raised over time?
Olon has raised $26.2M.
-
Who are Olon’s competitors?
IMCoPharma is a competitor of Olon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process